Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000234475 | SCV000289952 | benign | Spastic paraplegia | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000250154 | SCV000312153 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000624974 | SCV000743230 | benign | Charlevoix-Saguenay spastic ataxia | 2014-10-09 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000624974 | SCV000744370 | benign | Charlevoix-Saguenay spastic ataxia | 2015-09-21 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000250154 | SCV001476022 | benign | not specified | 2019-11-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000676368 | SCV001895977 | benign | not provided | 2019-11-13 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 23280630, 22287014, 19779133) |
Genome Diagnostics Laboratory, |
RCV001847973 | SCV002105007 | benign | Hereditary spastic paraplegia | 2021-10-29 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000676368 | SCV005230850 | benign | not provided | criteria provided, single submitter | not provided | ||
Mayo Clinic Laboratories, |
RCV000676368 | SCV000802144 | likely benign | not provided | 2016-03-08 | no assertion criteria provided | clinical testing | |
Natera, |
RCV000624974 | SCV001453560 | benign | Charlevoix-Saguenay spastic ataxia | 2020-09-16 | no assertion criteria provided | clinical testing | |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000250154 | SCV001952453 | benign | not specified | no assertion criteria provided | clinical testing |